In the present study, PNO1 was overexpressed in lung adenocarcinoma, and its inhibition by CRISPR/Cas9 technology inhibited cell proliferation, motility, migration, and invasion, and induced apoptosis. Here, PNO1 is linked to lung adenocarcinoma.